Chronic Lymphocytic Leukemia Research

50 ta ish

1. Karakolidine

   Shakhnoza S. Azimova, Marat S. Yunusov

   BobChronic Lymphocytic Leukemia Research20120 iqtibos

   ABIABI:AkademIndex/openalex/2012.chapter.007632

2. Asimilobine

   Shakhnoza S. Azimova, Marat S. Yunusov

   BobChronic Lymphocytic Leukemia Research20120 iqtibos

   ABIABI:AkademIndex/openalex/2012.chapter.007649

3. TREATMENT RESULTS ACCORDING TO CELLULAR SUBTYPES OF GASTRIC MALT LYMPHOMA

   M. Mallaev, R. Abdusattarov

   MaqolaLymphoma Diagnosis and TreatmentHematological Oncology20170 iqtibos

   ABIABI:AkademIndex/openalex/2017.article.000626

4. T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE OF THE TREATMENT PROTOCOL ALL-MB-2008 IN UZBEKISTAN

   Bakhramov Saidjalol Makhmudovich, Ibragimova Sapura Zakhidovna

   MaqolaAcute Lymphoblastic Leukemia researchJournal of Research in Health Science20180 iqtibos

   ABIABI:AkademIndex/openalex/2018.article.000671

5. Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database

   Elisabetta Abruzzese, Anna Turkina, Jane F. Apperley +21

   MaqolaChronic Myeloid Leukemia TreatmentsBlood20190 iqtibos

   ABIABI:AkademIndex/openalex/2019.article.000226

6. AB0001 ASSOCIATION OF MDR1 GENE G2677T POLYMORPHISM WITH METHOTREXATE RESISTANCE IN PATIENTS WITH UZBEK RHEUMATOID ARTHRITIS

   Nargiza Abdurakhmanova, Khalmurad Akhmedov

   MaqolaChronic Lymphocytic Leukemia ResearchAnnals of the Rheumatic Diseases20190 iqtibos

   ABIABI:AkademIndex/openalex/2019.article.002039

7. Clinical observation of chronic myeloid leukemia with variant translocation and supplementary rearrangement t(1;8)(q23;q24.3)

   Yu. Yu. Assesorova, L. K. Mustafina, Saniyat Yusupova +1

   MaqolaChronic Myeloid Leukemia TreatmentsRussian journal of hematology and transfusiology20210 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.009425

8. SPECIFIC FEATURES OF THE GLAUTEX DRAINAGEIMPLANTATION TECHNIQUE IN SURGICAL TREATMENT OF CONGENITALGLAUCOMA

   Z.R. Nazirova, DilfuzaTurakulova, Lola Djananovna Babadjanova

   MaqolaOcular Diseases and Behçet’s SyndromeZenodo (CERN European Organization for Nuclear Research)20210 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.012333

9. CLINICAL EFFICACY AND TOLERABILITY OF INFLIXIMAB IN PATIENTS WITH SEVERE ANKYLOSING SPONDYLITIS

   Мukhammadievа S.М, Nabievа D.A, Abduazizova N.X +1

   MaqolaImmunodeficiency and Autoimmune DisordersZenodo (CERN European Organization for Nuclear Research)20220 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.009375

10. Farzandimiz - yuz pardamiz

    Muminova Asem Seytmuratovna

    MaqolaChronic Lymphocytic Leukemia ResearchZenodo (CERN European Organization for Nuclear Research)20220 iqtibos

    ABIABI:AkademIndex/openalex/2022.article.015433

11. Clinico-demographic differences and severity of rheumatoid arthritis.

    Nauman Ismat Butt, Fahmina Ashfaq, Osama Habib +3

    MaqolaRheumatoid Arthritis Research and TherapiesThe Professional Medical Journal20230 iqtibos

    ABIABI:AkademIndex/openalex/2023.article.003590

12. CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management

    Bekhzodkhon Bakhodirov, Kamoliddin Olimjonov, Элдор Исхаков +7

    MaqolaChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

    ABIABI:AkademIndex/openalex/2023.article.003956

13. POSTER: CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management

    Bekhzodkhon Bakhodirov, Kamoliddin Olimjonov, Элдор Исхаков +7

    MaqolaChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

    ABIABI:AkademIndex/openalex/2023.article.010137

14. POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment

    Olga Kulemina, Julia Yakovleva, Natalia Lazorko +6

    MaqolaChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

    ABIABI:AkademIndex/openalex/2023.article.010138

15. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial

    Jane F. Apperley, Jörge E. Cortes, Elias Jabbour +21

    MaqolaChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

    ABIABI:AkademIndex/openalex/2023.article.010140

16. MDS-580 Case Report of Myelodysplastic Neoplasm (MDS) Hiding Under Immune Thrombocytopenic Purpura (ITP)

    Doskhan Orazkhanov, T Farhodjon, Iskhakov Eldor +5

    MaqolaMyeloproliferative Neoplasms: Diagnosis and TreatmentClinical Lymphoma Myeloma & Leukemia20230 iqtibos

    ABIABI:AkademIndex/openalex/2023.article.010141

17. A new perspective on therapies involving B-cell depletion in autoimmune diseases

    Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Ahmed Hjazi +7

    MaqolaChronic Lymphocytic Leukemia ResearchMolecular Biology Reports20240 iqtibos

    ABIABI:AkademIndex/openalex/2024.article.001776

18. Is early inclusion of neratinib with HER blockers possible in the treatment of stage 4 HER2 positive cancer?

    Zilola Avazovna Olimova

    MaqolaHER2/EGFR in Cancer ResearchJournal of Clinical Oncology20240 iqtibos

    ABIABI:AkademIndex/openalex/2024.article.007521

19. Correction: A new perspective on therapies involving B-cell depletion in autoimmune diseases

    Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Ahmed Hjazi +7

    BoshqaDiabetes and associated disordersMolecular Biology Reports20240 iqtibos

    ABIABI:AkademIndex/openalex/2024.other.000007

20. Optimizing ibrutinib bioavailability: Formulation and assessment of hydroxypropyl-β-cyclodextrin-based nanosponge delivery systems

    Sunitha Sampathi, Nitiraj Kulkarni, D. V. R. N. Bhikshapathi +4

    MaqolaChronic Lymphocytic Leukemia ResearchCurrent Research in Pharmacology and Drug Discovery20250 iqtibos

    ABIABI:AkademIndex/openalex/2025.article.000278

21. ALL-106: Outcomes of Blinatumomab, the Initial Phase of Chemotherapy in Children With B-Cell Acute Lymphoblastic Leukemia: A Single-Center Study

    Sapura Ibragimova, Albina Klevleeva, Nargiza Babakhanova +4

    MaqolaAcute Lymphoblastic Leukemia researchClinical Lymphoma Myeloma & Leukemia20250 iqtibos

    ABIABI:AkademIndex/openalex/2025.article.008095

22. THE IMPORTANCE OF IMMUNOHISTOCHEMISTRY IN THE DIAGNOSIS OF HODGKIN'S LYMPHOMA

    Kadamova M.A.

    MaqolaLymphoma Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

    ABIABI:AkademIndex/openalex/2026.article.000586

23. THE IMPORTANCE OF IMMUNOHISTOCHEMISTRY IN THE DIAGNOSIS OF HODGKIN'S LYMPHOMA

    Kadamova M.A.

    MaqolaLymphoma Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

    ABIABI:AkademIndex/openalex/2026.article.000632

24. Mycobacterial Infections in Patients With Hairy Cell Leukemia: A Systematic Review of Published Cases

    Praveen Kumar Tirlangi, Venkata Swathi Kiran Pothumarthy, Adil Rashid Khan +3

    MaqolaChronic Lymphocytic Leukemia ResearchOpen Forum Infectious Diseases20260 iqtibos

    ABIABI:AkademIndex/openalex/2026.article.003678

25. DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF IMMUNOLOGICAL MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A REVIEW OF CONTEMPORARY LITERATURE

    Нафиса Аминова

    MaqolaChronic Lymphocytic Leukemia ResearchScientific and Innovative Therapy20260 iqtibos

    ABIABI:AkademIndex/openalex/2026.article.013891